Related references
Note: Only part of the references are listed.FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Daniel Edmonston et al.
NATURE REVIEWS NEPHROLOGY (2020)
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Signe Sparre Beck-Nielsen et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Bone turnover markers: are they clinically useful?
Richard Eastell et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know
Pierre Delanaye et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling
Riikka E. Makitie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
Seiji Fukumoto
FRONTIERS IN ENDOCRINOLOGY (2018)
Rare Copy Number Variants in Array-Based Comparative Genomic Hybridization in Early-Onset Skeletal Fragility
Alice Costantini et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization
Anders J. Kampe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children
Elisa Holmlund-Suila et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3
Katherine Wesseling-Perry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
FGF23 Is Not Associated With Age-Related Changes in Phosphate, but Enhances Renal Calcium Reabsorption in Girls
Deborah M. Mitchell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants
A. J. Kampe et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults
Riikka E. Makitie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Osteoporosis and Bone Mass Disorders: From Gene Pathways to Treatments
Fernando Rivadeneira et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
The Skeletal Effects of Inhaled Glucocorticoids
Stephanie A. Sutter et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
FGF23 gene variation and its association with phosphate homeostasis and bone mineral density in Finnish children and adolescents
Minna Pekkinen et al.
BONE (2015)
A Novel Splice Mutation in PLS3 Causes X-linked Early Onset Low-Turnover Osteoporosis
Christine M. Laine et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Calcium binding is essential for plastin 3 function in Smn-deficient motoneurons
Alison N. Lyon et al.
HUMAN MOLECULAR GENETICS (2014)
Osteoporosis Caused by Mutations in PLS3: Clinical and Bone Tissue Characteristics
Somayyeh Fahiminiya et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription
Tomer Meir et al.
KIDNEY INTERNATIONAL (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
PLS3 Mutations in X-Linked Osteoporosis with Fractures
Fleur S. van Dijk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta
Christine M. Laine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Tenascin-C Downregulates Wnt Inhibitor Dickkopf-1, Promoting Tumorigenesis in a Neuroendocrine Tumor Model
Falk Saupe et al.
CELL REPORTS (2013)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sclerostin and Dickkopf-1 in Renal Osteodystrophy
Daniel Cejka et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The role of Dickkopf-1 in bone development, homeostasis, and disease
Joseph J. Pinzone et al.
BLOOD (2009)
Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy
Gabriela E. Oprea et al.
SCIENCE (2008)
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia
Ji Li et al.
BONE (2006)
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
A Bafico et al.
NATURE CELL BIOLOGY (2001)
An atomic model of actin filaments cross-linked by fimbrin and its implications for bundle assembly and function
N Volkmann et al.
JOURNAL OF CELL BIOLOGY (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
